Scientific Program _ interno

  • Timetable
  • Timetable full
  • Timetable light
  • Day by day
  • Sessions
  • Speakers
  • Print
  • Speakers
  • Tracks

Opening Lecture

  • (OL01) Novel neuroendocrine regulators: from puberty to hot flushes

    • Richard Anderson Novel neuroendocrine regulators: from puberty to hot flushes
  • (OL02) Embryo as the driving force for successful reproduction: role of Pre Implantation Factor (PIF)

    • Eytan Barnea Embryo as the driving force for successful reproduction: role of Pre Implantation Factor (PIF)

Key Lecture

  • (KL01) Human tissue engineering

    • Josef M. Penninger Human tissue engineering
  • (KL02) The human yolk sac, perhaps the most important transient organ

    • Frederick Naftolin The human yolk sac, perhaps the most important transient organ
  • (KL03) Freeze all for all?

    • Basil Tarlatzis Freeze all for all ?
  • (KL04) Endometrial receptivity

    • Carlos Simon Endometrial receptivity
  • (KL05) DHEA: still a mysterious substance - from a pre-hormone to an adrenal regulator

    • Andrea Genazzani DHEA: still a mysterious substance - from a pre-hormone to an adrenal regulator
  • (KL06) Translational research with thyroid hormone in the placenta

    • Takeshi Maruo Translational research with thyroid hormone in the placenta
  • (KL07) Why is estetrol a different and safer estrogen: the paradigm for use in contraception and menopause

    • Jean Michel Foidart Why is Estetrol a different and safer Estrogen: the paradigm for use in contraception and menopause
  • (KL08) Emerging health issues for women in the reproductive years- findings from the Grollo-Ruzenne Study

    • Susan Davis Emerging health issues for women in the reproductive years- findings from the Grollo-Ruzenne study
  • (KL09) Benign uterus disease and infertility: new approaches. IVF or surgery: when, why and outcome

    • Leila Adamyan Benign uterus disease and infertility: new approaches. IVF or surgery: when, why and outcome
  • (KL10) Sex, gender, and the brain

    • Walter Rocca Sex, gender, and the brain
  • (KL11) Dreams and Gender

    • Zipi Dolev Dreams and Gender
  • (KL12) TBD

    • Marek Ruchala tbd

Symposium

  • Adolescence and PCOS (symp01) Adolescence

    • Michèle Lachowksy Adolescence: a discovery of the "new" body
    • Stefano Luisi Management of endometriosis in teenagers
    • Laura Gaspari Adolescent and cosmetics: an high risk association
    • Camil Castelo Branco Sexuality and quality of life in PCOS
  • Adolescence and PCOS (symp02) Neuro-Endocrinology/FHA

    • Blazej Meczekalski Kisspeptin role in reproductive functions and dysfunctions
    • Rossella Nappi Sexual dysfunction in functional hypothalamic amenorrhea
    • Vincenzina Bruni The new functional hypotalamic amenorrheas
    • Richard Anderson Interactions between kisspeptin and neurokinins in the central control of ovulation
  • Adolescence and PCOS (symp03) PCOS: the beginning

    • de Zegher Francis Early origins of PCOS
    • Sarah Berga Brain Phenotype in PCOS – androgens, anovulation, and gender
    • Luigi Devoto Endocrine and molecular features involved in follicular arrest of PCOS women
    • Lourdes Ibanez Diagnosis & treatment of adolescent PCOS
  • Adolescence and PCOS (symp04) PCOS

    • Nazareth Amala Lovetto Polycystic ovary and it’s endocrine challenges
    • Xiangyan Ruan Management of PCOS women preparing pregnancy
    • Duru Shah Infertility management in lean v/s obese PCOS
    • Bart Fauser PCOS, pregnancy complications and children outcomes
  • Adolescence and PCOS (symp05) Androgen

    • Martin Birkhaeuser Androgen substitution – risks and benefits
    • Susan Davis The global position statement on androgens in women - where to from here
    • Nick Panay Androgenic options for women - where are we now?
  • Adolescence and PCOS (symp06) Insulin Resistance / Metabolic Syndrome

    • Andrzej Milewicz Metformin and women health - what is new ?
    • Svetlana Vujovic The role of insulin resistance in benign breast disease
    • Peter Chedraui Inflammation and the metabolic syndrome during the menopausal transition
    • Giulia Palla Fat and metabolic risk in pregnancy
  • Contraception (symp07) Progesterone, Progestogens and theyr receptors

    • Luigi Devoto Progesterone and progesterone receptors protagonist from ovulation to pregnancy
    • Antonio Cano Progestogens and cancer: lessons learnt from the breast with a message on endometrium
    • Takeshi Maruo Translational research with progesterone in the uterus: from bedside to bench and from bench to bedside
    • Adolf Schindler Progestogens and immunology
  • Contraception (symp08) SERMS and SPRMS

    • Jean Francois Arnal Recent advances in the understanding of the mechanisms of action of SERMs
    • Santiago Palacios The challenge of SERMs
    • Nathalie Chabbert-Buffet Ulipristal acetate, endometrium and breast
    • Bruno Mozzanega Ulipristal Acetate and Levonorgestrel in emergency contraception
  • Contraception (symp09) Endocrine Disruptors

    • Andrzej Milewicz Endocrine disruptors and women health
    • Charles Sultan Endocrine disruptors and reproduction
    • Gian Carlo Di Renzo Toxic chemicals in the environment and reproductive outcome
    • Marco Palumbo Endocrine disruptors and risk of endometriosis
  • Contraception (symp10) Contraception

    • Alfred Mueck Contraception: MEC of WHO – what should be changed ?
    • Cuauhtemoc Celis Non-contraceptive uses of hormonal contraceptives
    • Nilson De Melo Extended and continuous regimens of combined hormonal contraceptive methods
    • David Serfaty Hormonophobia in Contraception, what to do ?
  • Contraception (symp11) Dealing with side effects of hormone contraception

    • Johannes Bitzer Mood
    • Angelica Linden Hirschberg Influence of combined oral contraceptives and the menstrual cycle on sexual function in young women
    • Rossella Nappi Headache
    • Gabriele Merki Contraception in women with BRCA1/BRCA2 mutation
  • Endometriosis (symp12) Premenstrual disorders: what we know and what we do not know about the late-luteal enigmatic condition

    • Tamaki Matsumoto To what extent and how is autonomic nervous system activity associated with the diverse psychophysiological symptoms in the premenstrual phase?
    • Johannes Bitzer Dysmenorrhea and premenstrual disorders
    • Fabio Facchinetti Cathamenial headache and pre-menstrual syndrome
    • John Studd Premenstrual disorders, perinatal depression and menopausal syndrome
  • Endometriosis (symp13) Endometriosis - updates from basic science

    • Stefano Angioni Metabolomic characteristics in endometriosis patients
    • Caterina Exacoustos Accuracy of ultrasound evaluation of endometriosis using an integration of the Enzian classification
    • Robert Taylor Neurotrophins and cytokines in endometriosis pain
    • Paolo G. Artini Morphokinetics in embryos from patients with endometriosis
  • Endometriosis (symp14) Ultrasound evaluation of pelvic endometriosis

    • Steven Goldstein Can we diagnose endometriosis with ultrasound rather than laparoscopy ?
    • Caterina Exacoustos Evaluation deep infiltrating endometriosis is a staging of the disease possible
    • Dirk Timmerman Adenomyosis ultrasound diagnosis
    • Silvia Vannuccini Endometriosis and cancer: prevention and diagnosis
  • Endometriosis (symp15) Endometriosis’ therapies

    • Costantino Di Carlo The etonogestrel contraceptive implant as a therapy for endometriosis
    • Felice Petraglia Endometriosis induced pain: the treatment strategy
    • Tobie De Villiers Medical management of endometriosis, present and future with special reference to MHT in the patient previously diagnosed with endometriosis
    • Lydia Scemama Endometriosis and the menopause : why the question merits our full attention
  • Endometriosis (symp16) Microbioma

    • Stefano Lello Steroid metabolism and microbioma
    • Lydia Scemama Microbiota, hormones and the genito-urinary-syndrome in menopause
    • Gary Ventolini Novel discoveries on vaginal microbiome: is there a future role for Lactobacilli therapeutic application ?
    • Inmaculada Moreno Uterine microbiota in implantation and human pregnancy
  • IVF and Pregnancy (symp17) Implantation

    • Robert Taylor Does inflammation perturb the embryo-endometrial dialog ?
    • Felice Petraglia Stress and implantational failure
    • Carlos Simon Assessing endometrial receptivity
    • Vincenzo De Leo New players in the endometrium-embryo crosstalk
  • IVF and Pregnancy (symp18) Pre Implantation Factor (PIF)

    • Nicoletta Di Simone PIF protects against pregnancy loss
    • Martin Mueller PIF based viable embryo detection in IVF and in vivo
    • Marco Sbracia PIF diagnostic and therapeutic potential in endometriosis
    • Michael Paidas Prospects of using PIF for transplant acceptance – gynecological focus
    • Maria Rosa Raspolini PIF as marker for prostate cancer invasiveness
  • IVF and Pregnancy (symp19) Recent development in IVF

    • Georg Griesinger Luteal phase support with oral dydrogesterone: what is the evidence?
    • Ernest Loumaye The use of a novel oxytocin receptor antagonist, nolasiban, prior to embryo transfer: does it help ?
    • Marco Palumbo Strategies of luteal support in IVF
    • Bruno Lunenfeld Which patients need LH in addition to FSH
  • IVF and Pregnancy (symp20) Ovarian stimulation

    • Bart Fauser Ovarian stimulation: a key factor in infertility treatment
    • Vincenzo De Leo Ovulation induction in PCOS women: news strategies
    • Basil Tarlatzis Ovarian stimulation for IVF in poor responders
    • Joseph Schenker Induction ovulation and trombo-embolism
  • IVF and Pregnancy (symp21) Pregnancy

    • Fabio Facchinetti Inositols impact in fetal programming
    • Herbert Valensise Maternal haemodynamics and IUGR diagnosis and treatment
    • Federico Mecacci Pregnancy outcome and metabolic syndrome
    • Antonio Lanzone Endocrino-obstetric approach in the evaluation of gestational diabetes
  • Menopause (symp22) Peri-Menopause

    • Nazareth Amala Lovetto The endocrinology of menpause transition
    • Peter Chedraui Inflammation and the metabolic syndrome during the menopausal transition
    • Peter Schmidt Mood disorders during reproductive transitions: circuit and cellular substrates of risk
    • David Vasquez-Awad Contraception in menopause transition
  • Menopause (symp23) Menopause : from symptoms to risks

    • Tommaso Simoncini Metabolic prevention at menopause
    • Pauline Maki Hot flashes and cognition: the role of cortisol
    • Jean Francois Arnal Hormonal treatment and the arterial risk: an integrative view from experimental and clinical studies
    • Andrea Giannini Advance in E-health: test of an adaptive App to reduce the cardiovascular and metabolic risks for pre-menopause- menopause women
  • Menopause (symp24) Estradiol, Steroid-Regulated Genes, Brain Function and behavior of mice and women

    • Peter Schmidt Differential effects of estradiol exposure in women
    • Shau-Ming Wei Variations in Sex-Steroid Regulated Genes: ovarian steroid hormones modulate working-memory related brain function in women
    • Jordan Marrocco Cross-species epigenetic signature induced by ovarian hormones
    • Frederick Naftolin (Discussant) Closing remarks
  • Menopause (symp25) The physiopathological significance of neuroactive steroid synthesis and metabolism

    • Michael Schumacher Cerebroprotection by progesterone metabolites following ischemic stroke
    • Roberto Cosimo Melcangi Sex dimorphic neurosteroidogenesis: physiopathological role
    • Roberto Frau Alterations in progesterone metabolism mediate psychotic-like phenotypes induced by sleep deprivation
    • Roberta Brinton Diaz Neurosteroid regulation of lipid phenotype in ApoE3 and ApoE4 carriers
  • Menopause (symp26) Neurosteroids and neurogenesis and aging brain

    • Michael Schumacher Protective effects of neurosteroids in the aging brain
    • Roberta Brinton Diaz Identifying Alzheimer's risk at menopause: therapeutic opportunities to prevent or delay Alzheimer's
    • Regine Sitruk - Ware Nestorone and myelin regeneration
    • Pauline Maki Protective effects of neurosteroids in the aging brain
  • Menopause (symp27) Sleep disorders in women

    • Rosalia Silvestri Sleep disorders in pregnancy:maternal and fetal consequences
    • Eus Van Someren Insomnia in women
    • Enrica Bonanni Vasomotor symptoms and sleep disorders in menopause
    • Stephanie S. Faubion Sleep and sexual function: is there a connection ?
  • Menopause (symp28) Menopause therapy

    • Alfred Mueck Oral versus transdermal estradiol- difference beyond cardiovalscular risks
    • Nestor Siseles Cardiovascular risks in climacteric women: when begin the HMT
    • John Stevenson Is HRT now indicated for the primary prevention of CHD ?
    • Suvarna Khadilkar Preventing co-morbidities after menopause : a myth or reality ?
  • Menopause (symp29) VVA/GSM and regenerative gynecology

    • Angelica Linden Hirschberg Local estrogen for treatment of vulvovaginal atrophy in women with breast cancer receiving aromatase inhibitors
    • Cuauhtemoc Celis Vaginal health insights views & attitudes in LATAM
    • Santiago Palacios Should we talk about cosmetic gynecology or it is regenerative gynecology
    • Eleonora Russo Pelvic floor dysfunction at menopause and throughout ageing
  • Menopause (symp30) Rank from bone to endocrine cancer

    • Josef M. Penninger The role of RANKL in controlling physiological tissue remodeling in pregnancy
    • Antonio Cano Endometrium and Ovary
    • Eva Gonzales Suarez New therapeutic opportunities for the inhibition of RANK signaling in breast cancer
  • Menopause (symp31) Osteoporosis and intervertebral disk

    • Martin Birkhaeuser Postmenopausal osteoporosis. Is it a marker for other diseases ?
    • Mark Brincat Connective tissue and intervertebral disc changes with the menopause and treatment
    • Tobie De Villiers Optimal screening for osteoporosis: when and how
    • Suvarna Khadilkar Sarcopenia and bone health
  • Breast cancer (symp32) Breast cancers and diseases

    • Xiangyan Ruan Membrane bound receptors strong associated with breast cancer risk
    • Antonina Smetnik Cell molecular biomarkers of proliferative and non-proliferative benign breast disease
    • Nicoletta Biglia HRT in BRCA mutation carriers
    • Pierluigi Benedetti Panici HRT in breast cancer survivors
  • Gynecological surgery (symp33) Surgery

    • Stefano Angioni Impact of endometrioma surgery on ovarian reserve
    • Michelle Nisolle What is the place of surgery in deep endometriosis in infertile and pelvic pain patients?
    • Liselotte Mettler When are hysterectomies still indicated in the time of organ preserving sur
    • John J. Sciarra Alternatives to hysterectomy
  • Gynecological surgery (symp34) Ethical issues in reproduction

    • Bruno Imthurn Uterus transplantation – living or deceased donor ?
    • Pasquale Patrizio Experience with the USA surrogacy
    • Joseph Schenker Surrogacy and ovary transplantation: the ethical debate
    • James Pickar Ethics in medical publishing

Meet the Experts

  • (mte01) Stress

    • Alessandro Genazzani Stress and reproduction : a biologically integrated defensive system
    • Sarah Berga Reproductive consequences of stress – more than anovulation
  • (mte02) Anorexia nervosa

    • Charles Sultan Adolescent anorexia nervosa
    • Patrizia Monteleone Hormone replacement therapy in patience with anorexia nervosa
  • (mte03) Heavy mestrual bleeding and abnormal uterine bleeding

    • Vincenzina Bruni Heavy menstrual bleeding: diagnosis and medical treatment
    • John J. Sciarra Surgical treatment of abnormal uterine bleeding
  • (mte04) Vitamin D

    • Mark Brincat The Vit D story in reproductive medicine. Seperating the chaff from the wheat
    • Faustino Perez-Lopez Vitamin D supplementation after the menopause: which dosage ?
  • (mte05) HPV

    • Franco Borruto Hormonal influences in human papillomavirus infection
    • Antonio Perino Extending human papillomavirus (HPV) vaccination beyond adolescents and after treatment for high grade CIN
  • (mte06) Management of preterm labor

    • Paolo Mannella Autonomic nervous system and preterm labor: a novel management of early pregnancies ?
    • Frederick Naftolin A uterine pacemaker against preterm labor
  • (mte07) POI

    • Nick Panay Iatrogenic and spontaneous POI - evidence based management
    • Svetlana Vujovic Adrenal ageing in premature ovariance isufficency
  • (mte08) Extra gonadal effects of gonadotropins

    • Mone Zaidi Can we treat postmenopausal osteoporosis and obesity using a single anti-FSH agent ?
    • Xiaodong Fu Reproductive hormone and cardiovascular disease: the new mechanisms
  • (mte09) TBD

    • Walter Rocca Loss of ovarian hormones and accelerated somatic and mental aging
    • Liliana Gazzuola Rocca Psychiatric diseases and risk of gynecologic surgery

Scientific Society Symposium

  • Adenomyosis and Endometriosis: an update ( Organized by the Société Européenne de Langue Française et Allemande de Gynécologie et Obstétrique(SELFAGO/EGGG)

    Chairperson/s: René Druckmann , Adolf Schindler

    • Marcel Baeumler Sonographic features of adenomyosis and endometriosis
    • Jerome Mathis The impact of endometriosis on the outcome of assisted reproductive therapy, role of fertility preservation
    • Sara Imboden Deep infiltrating endometriosis: options in diagnostic and treatment
    • Walther Kuhn Endometriosis and ovarian cancer: is there any need for clinical decisions ?
    • Christian Singer Endometriosis and gynecological malignancies: similarities and distinctions
  • Actualizaciones en osteoporosis (Symposium organized by Federación Latinoamericana de Sociedades de Climaterio y Menopausia FLASCYM)

    Chairperson/s: Zully Benitez , Hoover Canaval

    • Rita Pizzi HRT and SERMS in osteoporosis. When and how ?
    • Konstantinos Tserotas Osteoporosis and combined and sequential bone anabolics. When to switch to anti- resorptives ?
    • Alejandra Belardo Vitamin D3, Calcium and exercise for osteoporosis
    • Luis Hernandez Discussion
    • Nilson De Melo Discussion
  • Body composition and health at menopause transition (Organized by Indian Menopause Society (IMS)

    Chairperson/s: Sunila Khandelwal

    • Sunila Khandelwal Syndromic approach to bone, muscle, and fat health
    • Meeta Singh DXA beyond bone health
  • Contraception in special situations (Symposium organized by SOCHEG - Sociedad Chilena de Endocrinología Ginecológica)

    • Patricio Barriga Contraception and depression
    • Rodrigo Macaya Contraception in hyperandrogenic women
    • Paula Vanhauwaert Contraception in drug addict women
  • How to choose the progestogens in HTM ? (Organized by AAPEC - Asociacion Argentina para el estudio del Climaterio

    Chairperson/s: Manuel Noelting

    • Maria Franchina Roles of neuron B and Kisspeptin in hot flashes
    • Blanca Campostrini How to choose the of progestogens in HTM?
    • Rita Caro Is THM good for the heart?
    • Claudia Rey Hormonal contraception in midlife women and bone metabolism
    • Ana Bucetta Discussion Panel
    • Gustavo Litterio Discussion Panel
  • Management of obesity in the women life (Organized by ALEG - Asociación Latinoamericana de Endocrinología Ginecológica

    Chairperson/s: Raul Dominguez Gonzalez , Alejandra Elizalde Cremonte

    • Konstantinos Tserotas Apostolakos Obese adolescent: management and prognosis
    • Carlos Lauro Valdez Zuniga Hormonal contraception in obese women
    • Selva Lima Obesity in the Climacteric? What awaits you ?
  • Ovarian dysfunction in reproductive years (Organized by SOBRAGE -Sociedade Brasileira de Ginecologia Endócrina

    Chairperson/s: Sebastião de Medeiros , Gustavo Arantes

    • Ana Carolina Japur De Sá Rosa Biomarkers of ovarian reserve. Practical approach
    • José Soares Jr The ovarian and uterine transplantation. Brazilian experience
    • Edmund Baracat PCOS: metabolic and reproductive syndrome
  • Scientific Society Symposium organized by EMAS - European Menopause and Andropause Society

  • Scientific Society Symposium organized by Ukrainian Society of Gynecologists Endocrinologists (USGE)

  • Stress and psychiatric symptoms in endocrine gynecological disorders(Organized by SAEGRE- Sociedad Argentina de Endocrinología Ginecológica y Reproductiva)

    Chairperson/s: Manuel Noelting

    • Sandra Demayo Stress in the life of women with PCOS: “a silent enemy”
    • Adriana Monastero Stress aging and cancer. Is it a domino effect ?
    • Karina Tozzi Psychiatric manifestations of Endocrine Disorders. Is it matter of gender ?
  • Symposium organized by (FLEG) Federación Latina de Endocrinología Ginecológica

    Chairperson/s: Gustavo Gomez Tabares , Rafael Camacho Mafla

    • Camil Castelo Branco Endocrine Disruptors
    • Sandra Demayo New perspectives in the treatment of the Polycystic Ovary Syndrome
    • Nilson R. De Melo Contraception and cardiovascular disease
  • Symposium organized by CEGIP - Capítulo de Endocrinología Ginecológica Paraguaya

  • Symposium organized by CSGE - Chinese Society of Gynecological Endocrinology

    Chairperson/s: Xiangyan Ruan , Alfred Mueck

    • Jie Wu Endocrine disruptors and POI
    • Wei Zhang The challenges of advanced maternal age in China
    • Xiangyan Ruan Fertility Protection:Report the data of the first official ovarian tissue cryobank in China
    • Hong Zang Long-term endometrial consequence of polycystic ovary syndrome in Chinese women
  • Symposium organized by DGGEF - German Society for Endocrinology and Fertility

  • Symposium organized by EPC - European Progestogen Club

    Chairperson/s: René Druckmann , Adolf Schindler

    • Tommaso Simoncini Clinical implication of progesterone receptor signaling
    • Sven Skouby What is the optimal luteal support in ART
    • Wolfgang Kuepker Progestogens and endometriosis
    • Alfred Mueck Progestogenes and menopause
    • Adolf Schindler Prevention or therapy in pregnancy disorders with progestogens
  • Symposium organized by GESI - Gynaecological Endocrine Society of India

  • Symposium organized by HSGE- Hungarian Society of Gynecological Endocrinology

  • Symposium organized by ICMC - International Consortium for Male Contraception

    Chairperson/s: David Serfaty

    • David Serfaty Update on ICMC activities
    • Cristina Meriggiola Landscape for male methods in the next decade
    • Richard Anderson Transdermal gel for men: efficacy study
  • Symposium organized by IMS - International Menopause Society

    Chairperson/s: Tommaso Simoncini , Susan Davis

    • Duru Shah Optimising health after menopause
    • Pauline Maki Identifying depression and maintaining happiness
    • Johannes Bitzer Relationships, sexuality and wellbeing
  • Symposium organized by LSGE- Latvian Society of Gynecological Endocrinology

  • Symposium organized by PCOSSI - PCOS Society of India

  • Symposium organized by PSGE -Polish Society of Gynecological Endocrinology

  • Symposium organized by SSEG - Serbian Society of the Endocrinology of Gender

Scholarship Course

  • (scholarship01) Scholarship-course 1 (reserved to scholarship awardees)

    • Charles Sultan Puberal maturation and its disorders
    • Alessandro Genazzani Insulin signaling and metabolic syndrome
    • Blazej Meczekalski The functional hypothalamic amenorrhea
    • Bart Fauser Polycystic ovary syndrome and fertility
    • Bruno Lunenfeld Decision taking in the process of treating female infertility
  • (scholarship02) Scholarship-course 2 (reserved to scholarship awardees)

    • Gian Carlo Di Renzo The luteal phase defects and early pregnancy loss
  • (scholarship03) Scholarship-course 3 (reserved to scholarship awardees)

    • Steven Goldstein Modern evaluation of abnormal uterine bleeding
  • (scholarship04) Scholarship-course 4 (reserved to scholarship awardees)

    • Peter Chedraui The peri-menopause: risks and management
  • (scholarship05) Scholarship course 5 (reserved to scholarship awardees)

    • Mark Brincat The post-manopausal hormone therapy

Corso Superiore di Ginecologia Endocrinologica AIGE

  • (CORSOAIGE01) Disendocrinie, insulino resistenza e riproduzione

    • Metella Dei Le alterazione dello sviluppo puberale: pubertà precoce e ritardata
    • Alessandro Genazzani Sindrome metabolica e iper-insulinismo
    • Massimo Tonacchera Le patologie tiroidee
    • Linda Vignozzi Le patologie ipofisarie e surrenaliche: l'iperprolattinemia e il deficit di 21 idrossilasi
  • (CORSOAIGE02) Terapie endocrine e fertilità

    • Antonio La Marca Terapia dell'infertilità da anovulazione
    • Gian Carlo Di Renzo Il sostegno della fase luteale
    • Alberto Revelli L’induzione dell’ovulazione nella PMA
    • Paolo G. Artini La paziente poor risponder
  • (CORSOAIGE03) Corso AIGE-FISS- La sessualità femminile: aspetti psicologici, endocrini, organici e loro ricadute cliniche

    • Vieri Boncinelli L'identità sessuale femminile
    • Rossella Nappi Aspetti endocrini della sessualità e loro modificazioni nel corso della vita
    • Roberta Giommi Anorgasmia nuove attenzioni e nuovi strumenti
    • Elena Lenzi Vaginismo e desiderio di maternità
    • Alessandra Graziottin Dolore pelvico: infiammazione e comorbilità

This site uses cookies for functional and analytical purposes. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. More info about cookies

Close